Sale!

GLRX5 Gene Anemia sideroblastic pyridoxine-refractory autosomal recessive Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GLRX5 gene plays a crucial role in the human body’s iron metabolism and red blood cell production. Mutations in this gene can lead to a condition known as sideroblastic anemia, specifically a form that is pyridoxine-refractory and inherited in an autosomal recessive manner. This means that individuals with this condition do not respond to the usual treatment with vitamin B6 (pyridoxine) and must inherit two copies of the mutated gene, one from each parent, to manifest the disease. Sideroblastic anemia is characterized by the body’s inability to properly incorporate iron into hemoglobin, leading to a form of anemia where the bone marrow produces ringed sideroblasts instead of healthy red blood cells.

To diagnose this specific genetic condition, a genetic test targeting the GLRX5 gene can be conducted. DNA Labs UAE offers such a test, providing a comprehensive analysis to identify mutations in the GLRX5 gene that are responsible for sideroblastic anemia. This genetic test is crucial for accurate diagnosis, allowing for appropriate management and treatment strategies to be implemented for affected individuals. The test is priced at 4400 AED and is conducted in a state-of-the-art laboratory setting, ensuring high-quality and reliable results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GLRX5 Gene Anemia Sideroblastic Pyridoxine-Refractory Autosomal Recessive Genetic Test

At DNA Labs UAE, we offer the GLRX5 Gene Anemia Sideroblastic Pyridoxine-Refractory Autosomal Recessive Genetic Test at a cost of AED 4400.0. This test is designed to diagnose individuals with GLRX5 gene-related anemia, specifically sideroblastic anemia that is pyridoxine-refractory.

Test Details

The GLRX5 gene is associated with sideroblastic anemia, pyridoxine-refractory. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated GLRX5 gene (one from each parent) in order to develop the condition. Sideroblastic anemia is characterized by abnormal production of red blood cells in the bone marrow. The body has difficulty incorporating iron into hemoglobin, resulting in a buildup of iron in the mitochondria of red blood cell precursors, leading to ineffective erythropoiesis.

Pyridoxine-refractory sideroblastic anemia is a subtype of sideroblastic anemia that does not respond to treatment with pyridoxine (vitamin B6), which is typically effective in other forms of the condition.

Test Components and Price

  • Test Name: GLRX5 Gene Anemia Sideroblastic Pyridoxine-Refractory Autosomal Recessive Genetic Test
  • Price: AED 4400.0
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Hematology
  • Doctor: Hematologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the GLRX5 Gene Anemia Sideroblastic Pyridoxine-Refractory Autosomal Recessive Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by GLRX5 Gene Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive NGS Genetic DNA Test gene GLRX5.

Test Methodology

The GLRX5 Gene Anemia Sideroblastic Pyridoxine-Refractory Autosomal Recessive Genetic Test utilizes NGS (Next-Generation Sequencing) technology. This technique allows for the simultaneous analysis of multiple genes and the identification of mutations or variations in the DNA sequence.

Benefits of Genetic Testing

Genetic testing can help confirm a diagnosis, provide information about the specific genetic cause of the condition, and guide treatment and management decisions. It is also useful for genetic counseling and family planning purposes, as it can help determine the risk of passing on the condition to future generations.

For more information or to schedule a GLRX5 Gene Anemia Sideroblastic Pyridoxine-Refractory Autosomal Recessive Genetic Test, please contact DNA Labs UAE.

Test Name GLRX5 Gene Anemia sideroblastic pyridoxine-refractory autosomal recessive Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GLRX5 Gene Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GLRX5 Gene Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive NGS Genetic DNA Test gene GLRX5
Test Details

The GLRX5 gene is associated with a type of anemia called sideroblastic anemia, pyridoxine-refractory. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated GLRX5 gene (one from each parent) in order to develop the condition.

Sideroblastic anemia is characterized by abnormal production of red blood cells in the bone marrow. In this condition, the body has difficulty incorporating iron into hemoglobin, the protein responsible for carrying oxygen in red blood cells. This leads to a buildup of iron in the mitochondria of red blood cell precursors, resulting in ineffective erythropoiesis.

Pyridoxine-refractory sideroblastic anemia refers to a specific subtype of sideroblastic anemia that does not respond to treatment with pyridoxine (vitamin B6), which is typically effective in other forms of the condition.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify mutations or variations in the DNA sequence. In the case of GLRX5 gene anemia, an NGS genetic test can be performed to identify any mutations or variations in the GLRX5 gene that may be causing the pyridoxine-refractory sideroblastic anemia.

Genetic testing can help confirm a diagnosis, provide information about the specific genetic cause of the condition, and guide treatment and management decisions. It can also be useful for genetic counseling and family planning purposes, as it can help determine the risk of passing on the condition to future generations.